These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 15055124)

  • 1. [Physicians notify on drug industry's marketing].
    Perman E
    Lakartidningen; 2004 Mar; 101(11):1014-5. PubMed ID: 15055124
    [No Abstract]   [Full Text] [Related]  

  • 2. [Scrutiny of drug marketing by drug industry].
    Perman E
    Lakartidningen; 2003 Apr; 100(16):1444-5. PubMed ID: 12756713
    [No Abstract]   [Full Text] [Related]  

  • 3. [Physicians report verbal drug information. Cases scrutinized by the IGM].
    Perman E
    Lakartidningen; 2004 Aug; 101(35):2648, 2650. PubMed ID: 15458219
    [No Abstract]   [Full Text] [Related]  

  • 4. Debunking myths in physician-industry conflicts of interest.
    Lichter PR
    Am J Ophthalmol; 2008 Aug; 146(2):159-71. PubMed ID: 18538299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The devil is in the details: the pharmaceutical industry's use of gifts to physicians as marketing strategy.
    McFadden DW; Calvario E; Graves C
    J Surg Res; 2007 Jun; 140(1):1-5. PubMed ID: 17481979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Physicians' travels abroad supported by drug industry scrutinized. Three cases surveyed by the IGM and the NBL].
    Perman E
    Lakartidningen; 2003 Dec; 100(51-52):4298-9. PubMed ID: 14756095
    [No Abstract]   [Full Text] [Related]  

  • 7. [Free lunch and samples are not bribes].
    Lagerlöf O
    Lakartidningen; 2003 Nov; 100(48):4017. PubMed ID: 14717103
    [No Abstract]   [Full Text] [Related]  

  • 8. [Drug industry's "offers" to health personnel].
    Møller N
    Ugeskr Laeger; 2007 Nov; 169(47):4081. PubMed ID: 18087788
    [No Abstract]   [Full Text] [Related]  

  • 9. [The pharmaceutical consultant plays a principal role in the industry's information].
    Klein S
    Nord Med; 1978 Apr; 93(3-4):84-5. PubMed ID: 643538
    [No Abstract]   [Full Text] [Related]  

  • 10. An intellectual virtue "vaccination" for physician-pharmaceutical industry interactions.
    Ahmadi Nasab Emran S
    Acad Med; 2015 Jan; 90(1):30-2. PubMed ID: 25319170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Written drug advertisements].
    Kormeset PO
    Tidsskr Nor Laegeforen; 2006 Aug; 126(15):1946; author reply 1946-7. PubMed ID: 16915329
    [No Abstract]   [Full Text] [Related]  

  • 12. Conflict of interest in the physician interface with the biomedical industry.
    Minnigan H; Chisholm CD
    Emerg Med Clin North Am; 2006 Aug; 24(3):671-85. PubMed ID: 16877136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Physicians and drug industry--one more time].
    Rørtveit G
    Tidsskr Nor Laegeforen; 2008 Feb; 128(5):553. PubMed ID: 18311195
    [No Abstract]   [Full Text] [Related]  

  • 14. Leading the campaign to reduce conflicts of interest.
    Health Prog; 2009; 90(4):52-3. PubMed ID: 19603720
    [No Abstract]   [Full Text] [Related]  

  • 15. [Written drug advertisements--are they reliable?].
    Solhaug HR; Indermo H; Slørdal L; Spigset O
    Tidsskr Nor Laegeforen; 2006 May; 126(10):1314-7. PubMed ID: 16691265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [An innovation--the bribee decides about the bribe!].
    Svartholm R
    Lakartidningen; 2003 Dec; 100(49):4122. PubMed ID: 14717087
    [No Abstract]   [Full Text] [Related]  

  • 17. Is journalism the drug industry's new dance partner?
    Moynihan R
    BMJ; 2011 Nov; 343():d6978. PubMed ID: 22049523
    [No Abstract]   [Full Text] [Related]  

  • 18. Nurse practitioners' perceptions and participation in pharmaceutical marketing.
    Crigger N; Barnes K; Junko A; Rahal S; Sheek C
    J Adv Nurs; 2009 Mar; 65(3):525-33. PubMed ID: 19222650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharma industry--redressing the balance.
    Panay N; Fenton A
    Climacteric; 2008 Oct; 11(5):353-4. PubMed ID: 18781478
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pfizer urged to respond to criticism and participate in the public debate].
    Bengt J
    Lakartidningen; 2005 Feb 21-27; 102(8):574-5. PubMed ID: 15786910
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.